Results 201 to 210 of about 172,898 (261)

Protocol for fibrin-based endothelial-cardiomyocyte co-culture in a microfluidic device. [PDF]

STAR Protoc
Spanjersberg TCF, Klaassen A, Wubbolts R, van Dijk CGM, van der Velden J, Veltrop RJA, van der Harst P, Harakalova M, van Steenbeek FG.   +8 more
europepmc   +1 more source

The Impact of Surgical Trauma-Activated Platelet-Rich Fibrin on Mesenchymal Stromal Cells In Vitro. [PDF]

Cells
Verboket RD, Usov L, Bohl I, Neijhoft J, Penna-Martinez M, Marzi I, Henrich D.   +6 more
europepmc   +1 more source

A Growing Dark Mass in a Patient With a History of Trauma

JEADV Clinical Practice, EarlyView.
Takahiro Hase, Keisuke Imafuku, Teruki Yanagi, Arisa Tanaka, Ayame Kimura, Suguru Kurosawa, Takashi Seo, Hideyuki Ujiie   +7 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fibrin sealant

Current Opinion in Hematology, 1996
Fibrin sealant consists of fibrinogen and thrombin solutions, which generate a crosslinked fibrin clot in a process that mimics the last stage of the physiologic coagulation system. Fibrin sealants have been used widely in Europe in the past two decades for hemostasis, sealing, and as a vehicle for drugs and growth factors, and as a biologic glue. This
U, Martinowitz, R, Saltz
openaire   +2 more sources

Fibrinogen and Fibrin

2020
Fibrinogen is a large glycoprotein, synthesized primarily in the liver. With a normal plasma concentration of 1.5-3.5 g/L, fibrinogen is the most abundant blood coagulation factor. The final stage of blood clot formation is the conversion of soluble fibrinogen to insoluble fibrin, the polymeric scaffold for blood clots that stop bleeding (a protective ...
Rustem I, Litvinov, Marlien, Pieters, Zelda, de Lange-Loots, John W, Weisel   +3 more
openaire   +2 more sources